Braeburn owns the marketing and sales rights to probuphine. I would not look for them to provide ongoing press releases as to the formulary status etc of probuphine. I would however look for them to announce an OUS deal which will include an upfront payment and milestones. I would also expect them to exit this qtr with more than 30 Million in the bank. For all the Carls etc out there this makes the company trading at 3x cash with no debt and a nice little pipeline! Good luck to all....there is no shortage of addicts out there.